Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 11 weeks
Awards & highlights
QiGong Trial Summary
This trial will evaluate the feasibility and effectiveness of a QiGong program for treating chemotherapy-induced peripheral neuropathy in cancer patients.
Eligible Conditions
- Cancer
- Peripheral Neuropathy
QiGong Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 11 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~11 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Objective Modified Total Neuropathy Scale (mTNS) score
Subjective Neurotoxicity Subscale score
Secondary outcome measures
Attendance
Emotional Well-Being
Functional Well-Being
+7 moreQiGong Trial Design
1Treatment groups
Experimental Treatment
Group I: Qi GongExperimental Treatment1 Intervention
Weekly QiGong for Chemotherapy-Induced Neuropathy classes for 10 weeks
Find a Location
Who is running the clinical trial?
Arash Asher, MDLead Sponsor
3 Previous Clinical Trials
73 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger